Saffron extracts alleviate cardiomyocytes injury induced by doxorubicin and ischemia-reperfusion in vitro

References

• Abdullaev F. (2002). Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med 227:20–25
   PubMed Web of Science ®Google Scholar
• Akhlaghi M, Bandy B. (2009). Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. J Mol Cell Cardiol 46:309–317
   PubMed Web of Science ®Google Scholar
• Bast A, Kaiserová H, den Hartog GJ, et al. (2007). Protectors against doxorubicin-induced cardiotoxicity: flavonoids. Cell Biol Toxicol 23:39–47
   PubMed Web of Science ®Google Scholar
• Bedner E, Smolewski P, Amstad P, et al. (2000). Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. Exp Cell Res 259:308–313
   PubMed Web of Science ®Google Scholar
• Berthiaume JM, Wallace KB. (2007). Adriamycin-induced oxidative mitochondral cardiotoxicity. Cell Biol Toxicol 23:15–25
   PubMed Web of Science ®Google Scholar
• Cassavaugh J, Lounsbury KM. (2011). Hypoxia-mediated biological control. J Cell Biochem 112:735–744
   PubMed Web of Science ®Google Scholar
• Chahine N, Hanna J, Makhlouf H, et al. (2013). Protective effect of saffron extract against doxorubicin cardiotoxicity in isolated rabbit heart. Pharm Biol 51:1564–1571
   PubMed Web of Science ®Google Scholar
• Crivellari D, Bonetti M, Castiglione-Gertsch M, (2000). Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII. J Clin Oncol 18:1412–1422
   PubMed Web of Science ®Google Scholar
• Gabrielson K, Bedja D, Pin S, et al. (2007). Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury. Cancer Res 67:1436–1441
   PubMed Web of Science ®Google Scholar
• Gharanei M, Hussain A, Janneh O, et al. (2013). Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore. Toxicol Appl Pharmacol 268:149–156
   PubMed Web of Science ®Google Scholar
• Han X, Ren D, Fan P, et al. (2008). Protective effects of naringenin-7-O glucoside on doxorubicin induced apoptosis in H9C2 cells. Eur J Pharmacol 581:47–53
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. (2004). New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61:448–460
   PubMed Web of Science ®Google Scholar
• Hu ML. (2011). Dietary polyphenols as antioxidants and anticancer agents: more questions than answers. Chang Gung Med J 34:449–460
   PubMedGoogle Scholar
• Hu Y, Chen X, Pan TT, et al. (2008). Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/AKT pathways. Pflugers Arch 455:607–616
   PubMed Web of Science ®Google Scholar
• Huang SG. (2002). Development of a high throughput screening assay for mitochondrial membrane potential in living cells. J Biomol Screen 7:383–389
   PubMed Web of Science ®Google Scholar
• Ichihara S, Yamada Y, Kawai Y, et al. (2007). Roles of oxidative stress and Akt signaling in doxorubicin cardiotoxicity. Biochem Biophys Res Commun 359:27–33
   PubMed Web of Science ®Google Scholar
• Kalyanaraman B, Joseph J, Kalivendi S. (2002). Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 234–235:119–124
   PubMed Web of Science ®Google Scholar
• Kim DS, Kim HR, Woo ER. (2005). Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. Biochem Pharmacol 70:1066–1078
   PubMed Web of Science ®Google Scholar
• Kim DS, Woo ER, Chae SW. (2007). Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation. Life Sci 80:314–323
   PubMed Web of Science ®Google Scholar
• Lebrecht D, Geist A, Ketelsen UP, et al. (2007). Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats. Br J Pharmacol 151:771–778
   PubMed Web of Science ®Google Scholar
• Li JM, Shah AM. (2004). Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am J Physiol Regul Integr Comp Physiol 287:1014–1030
   PubMed Web of Science ®Google Scholar
• Listenberger LL, Ory DS, Schaffer JE. (2001). Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276:14890–14895
   PubMed Web of Science ®Google Scholar
• Makhlouf H, Saksouk M, Habib J, et al. (2011). Determination of antioxidant activity of saffron taken from the flower of Crocus sativus grown in Lebanon. Afr J Biotechnol 10:8093–8100
   Web of Science ®Google Scholar
• Malliopoulou V, Xinaris C, Mourouzis I. (2006). High glucose protects embryonic cardiac cells against simulated ischemia. Mol Cell Biochem 284:87–93
   PubMed Web of Science ®Google Scholar
• Martelli AM, Faenza I, Billi AM. (2006). Intranuclear 3′-phosphoinositide metabolism and Akt signaling: new mechanisms for tumorigenesis and protection against apoptosis? Cell Signa l18:1101–1107
   Web of Science ®Google Scholar
• Matsui T, Rosenzweig A. (2006). Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. J Mol Cell Cardiol 38:63–71
   Web of Science ®Google Scholar
• Mertens AC, Liu Q, Neglia JP, et al. (2008). Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 100:1368–1379
   PubMed Web of Science ®Google Scholar
• Minotti G, Menna P, Salvatorelli E, et al. (2004). Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229
   PubMed Web of Science ®Google Scholar
• Murphy E, Steenbergen C. (2008). Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev 88:581–609
   PubMed Web of Science ®Google Scholar
• Reeve JLV, Szegezdi E, Logue SE, et al. (2007). Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL. J Cel Mol Med 11:509–520
   PubMed Web of Science ®Google Scholar
• Safra T, Muggia F, Jeffers S, et al. (2000). Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol 11:1029–1033
   PubMed Web of Science ®Google Scholar
• Santos CX, Anilkumar N, Zhang M, et al. (2011). Redox signaling in cardiac myocytes. Free Radic Biol Med 50:777–793
   PubMed Web of Science ®Google Scholar
• Sawyer DB. (2013). Anthracyclines and heart failure. New Eng J Med 368:1154–1156
   PubMed Web of Science ®Google Scholar
• Skulachev VP, Anisimov VN, Antonenko YN, et al. (2009). An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta 1787:437–461
   PubMed Web of Science ®Google Scholar
• Spallarossa P, Garibaldi S, Altieri P. (2004). Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J Mol Cell Cardiol 37:837–846
   PubMed Web of Science ®Google Scholar
• Takemura G, Fujiwara H. (2007). Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis 49:330–352
   PubMed Web of Science ®Google Scholar
• Taniyama Y, Walsh K. (2002). Elevated myocardial Akt signaling ameliorates doxorubicin-induced congestive heart failure and promotes heart growth. J Mol Cell Cardiol 34:1241–1247
   PubMed Web of Science ®Google Scholar
• Wallace KB, Hausner E, Herman E, et al. (2004). Serum troponins as biomarkers of drug-induced cardiac toxicity. Toxicol Pathol 32:106–121
   PubMed Web of Science ®Google Scholar
• Wang Y. (2007). Mitogen-activated protein kinases in heart development and diseases. Circulation 116:1413–1423
   PubMed Web of Science ®Google Scholar
• Wattanapitayakul SK, Chularojmontri L, Herunsalee A. (2005). Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity. Basic Clin Pharmacol Toxicol 96:80–87
   PubMed Web of Science ®Google Scholar
• Yellon DM, Hausenloy DJ. (2007). Myocardial reperfusion injury. N Engl J Med 357:1121–1135
   PubMed Web of Science ®Google Scholar
• Zhang DX, Gutterman DD. (2007). Mitochondrial reactive oxygen species mediated signaling in endothelial cells. Heart Circulatory Physiol 292:H2023–H2031
   PubMed Web of Science ®Google Scholar